The aim of chemotherapy for mesothelioma is to palliate symptoms and improve survival.
Measuring response using CT is challenging because of the circumferential tumor growth …

Purpose Response evaluation with conventional criteria based on computed tomography
(CT) is particularly challenging in malignant pleural mesothelioma (MPM) due to its diffuse …

Background To evaluate the importance of assessing volume-based parameter of 18 F-FDG
PET/CT in patients with malignant pleural mesothelioma (MPM) for the prediction of …

Purpose Quantitative analyses on FDG PET for response assessment are increasingly used
in clinical studies, particularly with respect to tumours in which radiological assessment is …

Purpose Malignant pleural mesothelioma (MPM) is a disease with poor prognosis despite
multimodal therapy but there is variation in survival between patients. Prognostic information …

PURPOSE: Based on the complex growth pattern of MPM, conventional response
evaluation in this cancer entity is challenging. Therefore, there is growing interest in therapy …

Purpose: Existing prognostic systems for malignant pleural mesothelioma do not incorporate
imaging information. We aimed to identify the contribution of quantitative fluorodeoxyglucose …

Purpose This study investigated the diagnostic performance and prognostic value of
fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT in suspected malignant …

Purpose The purposes of this study were (1) to calculate the tumor volume in patients with
malignant pleural mesothelioma using computed tomography (CT) scan images and a …

Introduction To investigate the role of 18-fluorodeoxyglucose positron emission tomography-
computed tomography (18-FDG-PET-CT) in the surveillance of patients after multimodality …